Urgent.News

What's breaking now, across thousands of outlets.

More in Health & Medicine

Ginkgo Datapoints, Apheris Announce Founding Members of Antibody Developability Consortium

The consortium aims to address antibody development bottlenecks by creating standardized datasets and AI models that support earlier risk detection and more informed candidate selection.

  • Ginkgo Datapoints and Apheris form Antibody Developability Consortium.
  • AbbVie, Agenix, Lundbeck, and Takeda join founding members.
  • Gingko Datapoints will contribute proprietary antibody sequencing.

More from Tuesday 29 September →